Protagenic Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTIX and other ETFs, options, and stocks.About PTIX
Protagenic Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction.
CEOBarrett Evans
CEOBarrett Evans
Employees3
Employees3
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded1994
Founded1994
Employees3
Employees3
PTIX Key Statistics
Market cap2.62M
Market cap2.62M
Price-Earnings ratio-0.19
Price-Earnings ratio-0.19
Dividend yield—
Dividend yield—
Average volume51.44K
Average volume51.44K
High today$1.58
High today$1.58
Low today$1.32
Low today$1.32
Open price$1.44
Open price$1.44
Volume49.61K
Volume49.61K
52 Week high$14.28
52 Week high$14.28
52 Week low$1.12
52 Week low$1.12
Stock Snapshot
As of today, Protagenic Therapeutics(PTIX) shares are valued at $1.36. The company's market cap stands at 2.62M, with a P/E ratio of -0.19.
On 2025-12-31, Protagenic Therapeutics(PTIX) stock moved within a range of $1.32 to $1.58. With shares now at $1.36, the stock is trading +3.0% above its intraday low and -13.9% below the session's peak.
Trading volume for Protagenic Therapeutics(PTIX) stock has reached 49.61K, versus its average volume of 51.44K.
The stock's 52-week range extends from a low of $1.12 to a high of $14.28.
The stock's 52-week range extends from a low of $1.12 to a high of $14.28.
People also own
Based on the portfolios of people who own PTIX. This list is generated using Robinhood data, and it’s not a recommendation.